Psychiatry and Neurology, Neurology · Phoenix, AZ
NPI
1942317359
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
500 W Thomas Rd, Suite 300
Phoenix, AZ, 85013
Phone (602) 406-6262
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
522 services
Medicare patients, 2024
269
Average age 71
Drug cost, 2024
$1.3M
2,279 prescriptions
Company payments, 2025
$135K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steve S Chung was code 95720 (neurologic), 185 times for 83 patients. In total Steve S Chung billed 522 services in 15 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 185 | 83 | $151.50 | $28K |
| 95816 Neurologic | Facility | 100 | 98 | $37.86 | $3,786 |
| 95718 Neurologic | Facility | 67 | 56 | $101.76 | $6,818 |
| 95822 Neurologic | Facility | 50 | 45 | $37.26 | $1,863 |
| 95813 Neurologic | Facility | 34 | 33 | $58.95 | $2,004 |
| 95819 Neurologic | Facility | 26 | 26 | $42.91 | $1,116 |
| 99213 Office E&M - Established | Facility | 19 | 16 | $39.29 | $747 |
By year: 2022 $21K for 301 services; 2023 $23K for 327 services; 2024 $46K for 522 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steve S Chung prescribed most often to Medicare patients was Levetiracetam, with 257 prescriptions and refills. In total Steve S Chung wrote 2,279 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 257 | 367 | 44 | $11K |
| Lamotrigine Generic | 236 | 373 | 35 | $4,473 |
| Lacosamide Generic | 205 | 254 | 33 | $52K |
| Clobazam Generic | 167 | 195 | 22 | $50K |
| Briviact Brivaracetam | 162 | 166 | 17 | $239K |
| Zonisamide Generic | 144 | 198 | 25 | $6,860 |
| Clonazepam Generic | 118 | 122 | 26 | $1,185 |
| Xcopri Cenobamate | 115 | 115 | 14 | $179K |
| Topiramate Generic | 90 | 152 | 20 | $986 |
| Aptiom Eslicarbazepine Acetate | 79 | 85 | 12 | $185K |
| Divalproex Sodium Generic | 68 | 108 | 11 | $2,647 |
| Fycompa Perampanel | 62 | 66 | Under 11 | $75K |
| Oxcarbazepine Generic | 47 | 67 | Under 11 | $3,056 |
| Epidiolex Cannabidiol (Cbd) | 43 | 43 | Under 11 | $260K |
| Gabapentin Generic | 39 | 63 | Under 11 | $1,360 |
Brand drugs: 575 claims; generic drugs: 1,666 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steve S Chung $135K ($135K in general payments such as food, travel and fees) from 11 companies. The largest payer was Jazz Pharmaceuticals Inc. with $40K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.